Notably, STING activation has been shown to induce regulatory B cells that impair NK cell function in pancreatic cancer (35), suggesting a potential immunosuppressive role for Bregs in limiting STING-mediated anti-tumor immunity. This evidence concerns the gene STING1 and pancreatic neoplasm.